Yale Podnos, Chief Medical Officer at Starling Oncology, sold TOI on Jul 14, 2026
Prices as of Jul 30 · price update delayed · Every feed →
- Traded
- Jul 14, 2026
- Disclosed
- Jul 16, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
TOI since disclosure
−3.6%
after the sale
Similar stocks (XLV) since disclosure
+1.1%
XLV — its sector index fund
Change in closing price from Jul 16, 2026 (the first trading day on or after disclosure) to Jul 30, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLYale Podnos Chief Medical OfficerTOI Starling Oncology, Inc.$116Kdisclosed Jul 16 · filed 2 days after the trade